2018
DOI: 10.1016/j.jcv.2018.05.011
|View full text |Cite
|
Sign up to set email alerts
|

Low Zika virus seroprevalence among pregnant women in North Central Nigeria, 2016

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

5
21
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(27 citation statements)
references
References 24 publications
5
21
1
Order By: Relevance
“…Of interest, when modeling our data we concluded that the most probable mode of transmission in the tropical savannah region was nonepidemic and associated with low seroprevalence values, which is reminiscent of the low-rate endemic transmission that has been reported in Central Africa (Cameroon and Congo) (17,27) and West Africa (28,31). This transmission may correspond in part to sylvatic exposure.…”
Section: Discussionmentioning
confidence: 53%
See 1 more Smart Citation
“…Of interest, when modeling our data we concluded that the most probable mode of transmission in the tropical savannah region was nonepidemic and associated with low seroprevalence values, which is reminiscent of the low-rate endemic transmission that has been reported in Central Africa (Cameroon and Congo) (17,27) and West Africa (28,31). This transmission may correspond in part to sylvatic exposure.…”
Section: Discussionmentioning
confidence: 53%
“…We found an average ZIKV seroprevalence of ≈12%, ranging from 3.1% to 20.2% depending on the study site. Seroprevalence was higher than expected because recent surveys conducted in several Central and West Africa countries reported lower values: ≈5% in Cameroon (17), 0.1% in the Democratic Republic of the Congo (27) and 3.4% in Nigeria (28). Those countries have ecoclimatic conditions that have been typically associated with the circulation of ZIKV and its implication in the transmission to humans by peridomestic mosquitoes (i.e., tropical forested areas with nonhuman primates and sylvatic Aedes spp.…”
Section: Discussionmentioning
confidence: 87%
“…Recently, a number of serosurveys of ZIKV infections have been conducted in Oceania, Africa, Latin America, and the Caribbean. The seroprevalence was high in Micronesia (73%) [23], Brazil (63.3%) [24], Nicaragua (36 – 56%) [25], French Polynesia (49%) [26], Martinique (42.2%) [27], Bolivia (0 – 39%) [28], Suriname (35.1%) [29], French Guiana (18.8%) [30], Saudi Arabia (12.68%) [31], and Nigeria (10%) [32], but was less than 10% in Laos (9.9%) [33], Indonesia (9.1%) [17], Zambia (6.1%) [34], Cameroon (5%) [35], Rwanda (1.4%) [36], and Kenya (0.24 – 7.11%) [37]. However, the laboratory assays used were varied across the studies.…”
Section: Discussionmentioning
confidence: 99%
“…Serological data suggest that ZIKV transmission has occurred among humans, animals and mosquitoes throughout tropical Africa for more than 70 years; however, ZIKV epidemics were never reported, and fewer than 20 human infections were recorded [ 3 ] between its isolation and the first large epidemic, occurring in Micronesia in 2007 [ 4 ]. ZIKV gained new attention after its spread in the Pacific and then to the Americas [ 5 ], and in recent years serological studies were conducted in Africa, documenting the presence of ZIKV antibodies in humans [ 6 , 7 , 8 , 9 ]. Moreover, a ZIKV outbreak that occurred in Gabon in 2007 was retrospectively identified [ 10 ].…”
Section: Introductionmentioning
confidence: 99%